Beyond Geographies and Business Areas
We Build Partnerships That Transcend Boundaries
Driven by our passion for science, access, and ease – we partner to ensure progress for all.
Why Partner with Us
Robust global networks
A truly global company, connecting over 30 countries
Multiple areas of opportunity
From co-developing drugs to out-licensing – collaboration is key
Legacy of results and delivery
Over 25 years of forwarding science at Dr. Reddy’s Biologics
Our Network of Partners
- All
- In-licensing
- Out-licensing
- Co-development
Alvotech
Healthcare Pharmaceuticals Limited
Coya Therapeutics
Processes Involved Toward Partnership
Please expect to go through the following processes on the way to successful deal closure.
Write to us using the Enquiry Form below.
Non-Disclosure Agreement (NDA):
Business Case and Opportunity Assessment:
Term Sheet:
Due Diligence:
Licensing Agreement:
Supporting Agreements:
Our Network
- Publication
- 31-08-2021
A randomized, double-blind, parallel-group, single-dose comparative pharmacokinetic study of DRL_TZ, a candidate biosimilar of trastuzumab, with Herceptin (EU) in healthy adult males
- Publication
- 17-01-2024
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial
- Publication
- 21-12-2020
Safety and tolerability of Peg‑grafeel, a pegfilgrastim, for the prophylactic treatment of chemotherapy‑induced neutropenia and febrile neutropenia: A prospective, observational, postmarketing surveillance study in India
- Publication
- 09-10-2013
A Randomized, Multi Centre, Open-Label Study to Evaluate the Efficacy and Safety of Peg G-CSF as Compared to Grafeel in the Prophylaxis of Severe Neutropenia in Cancer Patients Receiving Cytotoxic Chemotherapy
Yamini Mehrotra
Product Dev.
Uggirala Chinna
Manufacturing
Aparna Panicker
Manufacturing
Rama Mohana
Warehouse
Manohar Kommu
Warehouse
Bricks of Biologics, appreciates the contribution and celebrates our people who are the building blocks of Dr. Reddy's Biologics.
Bricks of biologics in general refers to bio-bricks as genetic building blocks which are DNA sequences that can be assembled to create complex biological systems.